.Pharmacolibrary.Drugs.ATC.N.N02AA11 .Pharmacolibrary.Drugs.ATC.N.N02AA11| name: | Oxymorphone |
| ATC code: | N02AA11 | route: | oral |
| n-compartments | 1 |
Oxymorphone is a potent semi-synthetic opioid analgesic used for the management of moderate to severe pain. It acts primarily as a mu-opioid receptor agonist and is available in both immediate-release and extended-release oral formulations, as well as parenteral forms. Oxymorphone is approved for clinical use but is a controlled substance due to its abuse potential.
Pharmacokinetic parameters reported in healthy adult subjects (both males and females), under fasting conditions, following a single oral immediate-release dose.
Agema, BC, et al., & Koolen, SLW (2021). Population Pharmacokinetics of Oxycodone and Metabolites in Patients with Cancer-Related Pain. Cancers 13(11) –. DOI:10.3390/cancers13112768 PUBMED:https://pubmed.ncbi.nlm.nih.gov/34199534
Sloan, PA, & Barkin, RL (2008). Oxymorphone and oxymorphone extended release: a pharmacotherapeutic review. Journal of opioid management 4(3) 131–144. DOI:10.5055/jom.2008.0018 PUBMED:https://pubmed.ncbi.nlm.nih.gov/18717508
Benedek, IH, et al., & Fiske, WD (2011). Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release. Drug design, development and therapy 5 455–463. DOI:10.2147/DDDT.S24372 PUBMED:https://pubmed.ncbi.nlm.nih.gov/22162639